Recombinant Mouse IL-18/IL-1F4 Protein

Carrier Free

Catalog # Availability Size / Price Qty
9139-IL-050/CF
9139-IL-010/CF
9139-IL-500/CF

With Carrier

Catalog # Availability Size / Price Qty
9139-IL-050
9139-IL-010
9139-IL-500
Best Seller
Recombinant Mouse IL-18/IL-1F4 Protein Bioactivity
2 Images
Product Details
Citations (11)
FAQs
Reviews (1)

Recombinant Mouse IL-18/IL-1F4 Protein Summary

Product Specifications

Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to induce mouse IFN-gamma secretion by activated mouse T cells. The ED50 for this effect is 0.06-0.36 ng/mL.
Source
E. coli-derived mouse IL-18/IL-1F4 protein
Asn36-Ser192
Accession #
N-terminal Sequence
Analysis
Asn36 & Leu40
Predicted Molecular Mass
18 kDa
SDS-PAGE
17 kDa, reducing conditions

Product Datasheets

You must select a language.

x

9139-IL (with carrier)

You must select a language.

x

9139-IL/CF (carrier free)

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

9139-IL

Formulation Lyophilized from a 0.2 μm filtered solution in PBS, EDTA and DTT with BSA as a carrier protein.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

9139-IL/CF

Formulation Lyophilized from a 0.2 μm filtered solution in PBS, EDTA and DTT with trehalose.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Scientific Data

Bioactivity Recombinant Mouse IL-18/IL-1F4 Protein Bioactivity View Larger

Recombinant Mouse IL-18/IL-1F4 (Catalog # 9139-IL) induces IFN gamma secretion by activated mouse T cells. The ED50 for this effect is 0.06-0.36 ng/mL.

SDS-PAGE Recombinant Mouse IL-18/IL-1F4 Protein SDS-PAGE View Larger

1 μg/lane of Recombinant Mouse IL-18 (Catalog # 9139-IL) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by silver staining, showing a single band at 18 kDa.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: IL-18/IL-1F4

Interleukin-18 (IL-18) is a proinflammatory cytokine in the IL-1 family that exerts distinct immune effects depending on the local cytokine environment. It is expressed as a 24 kDa precursor by endothelial and epithelial cells, keratinocytes, gamma δ T cells, and phagocytes. The precursor is activated intracellularly by Caspase-1 mediated proteolysis to release the 17 kDa mature cytokine. The precursor can also be released by necrotic cells for extracellular cleavage by multiple proteases.
IL-18 activation is induced by infection or tissue damage and contributes to disease pathology in chronic inflammation (1-3). IL-18 binds to the widely expressed IL-18 R alpha which recruits IL-18 R beta to form the signaling receptor complex (4, 5). Its bioactivity is negatively regulated by interactions with IL-18 binding proteins and virally encoded IL-18BP homologs (6). In the presence of IL-12 or IL-15, IL-18 enhances anti-viral Th1 immune responses by inducing IFN-gamma production and the cytolytic activity of CD8+ T cells and NK cells (7, 8). In the absence of IL-12 or IL-15, however, IL-18 promotes production of the Th2 cytokines IL-4 and IL-13 by CD4+ T cells and basophils (9, 10). In the presence of IL-1 beta or IL-23, IL-18 induces the antigen-independent production of IL-17 by gamma δ T cells and CD4+ T cells (11). IL-18 also promotes myeloid dendritic cell maturation and triggers neutrophil respiratory burst (12, 13). In cancer, IL-18 exhibits diverse activities including enhancing anti-tumor immunity, inhibiting or promoting angiogenesis, and promoting tumor cell metastasis (14). Mature mouse IL-18 shares 63% and 91% amino acid sequence identity with mouse and rat IL-18, respectively (15).

References
  1. Dinarello, C.A. et al. (2013) Front. Immunol. 4:289.
  2. Smith, D.E. (2011) J. Leukoc. Biol. 89:383.
  3. Gu, Y. et al. (1997) Science 275:206.
  4. Torigoe, K. et al. (1997) J. Biol. Chem. 272:25737.
  5. Cheung, H. et al. (2005) J. Immunol. 174:5351.
  6. Novick, D. et al. (1999) Immunity 10:127.
  7. Fehniger, T.A. et al. (1999) J. Immunol. 162:4511.
  8. Yoshimoto, T. et al. (1998) J. Immunol. 161:3400.
  9. Yoshimoto, T. et al. (2000) Nat. Immunol. 1:132.
  10. Kroeger, K.M. et al. (2009) J. Leukoc. Biol. 86:769.
  11. Lalor, S.J. et al. (2011) J. Immunol. 186:5738.
  12. Li, J. et al. (2004) Cell. Immunol. 227:103.
  13. Elbim, C. et al. (2005) Clin. Diagn. Lab. Immunol. 12:436.
  14. Fabbi, M. et al. (2015) J. Leukoc. Biol. 97:665.
  15. Okamura, H. et al. (1995) Nature 378:88.
Long Name
Interleukin 18
Entrez Gene IDs
3606 (Human); 16173 (Mouse); 29197 (Rat); 397057 (Porcine); 574151 (Primate)
Alternate Names
Iboctadekin; IFN-gamma-inducing factor; IGIF; IGIFIL-1 gamma; IL18; IL-18; IL-18MGC12320; IL-1F4; IL1F4iboctadekin; IL-1g; Interferon gamma-inducing factor; interleukin 18 (interferon-gamma-inducing factor); Interleukin-1 gamma; interleukin-18

Citations for Recombinant Mouse IL-18/IL-1F4 Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

11 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Type 1 immunity enables neonatal thymic ILC1 production
    Authors: Tougaard, P;Pérez, MR;Steels, W;Huysentruyt, J;Verstraeten, B;Vetters, J;Divert, T;Gonçalves, A;Roelandt, R;Takahashi, N;Janssens, S;Buus, TB;Taghon, T;Leclercq, G;Vandenabeele, P;
    Science advances
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  2. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
    Authors: LaMarche, NM;Hegde, S;Park, MD;Maier, BB;Troncoso, L;Le Berichel, J;Hamon, P;Belabed, M;Mattiuz, R;Hennequin, C;Chin, T;Reid, AM;Reyes-Torres, I;Nemeth, E;Zhang, R;Olson, OC;Doroshow, DB;Rohs, NC;Gomez, JE;Veluswamy, R;Hall, N;Venturini, N;Ginhoux, F;Liu, Z;Buckup, M;Figueiredo, I;Roudko, V;Miyake, K;Karasuyama, H;Gonzalez-Kozlova, E;Gnjatic, S;Passegué, E;Kim-Schulze, S;Brown, BD;Hirsch, FR;Kim, BS;Marron, TU;Merad, M;
    Nature
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  3. Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge
    Authors: CM Schafer, S Martin-Alm, K Kurylowicz, N Dufton, L Osuna-Alma, ML Wu, CF Johnson, AV Shah, DO Haskard, A Buxton, E Willis, K Wheeler, S Turner, M Chlebicz, RP Scott, S Kovats, A Cleuren, GM Birdsey, AM Randi, CT Griffin
    bioRxiv : the preprint server for biology, 2023-02-11;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Bioassay
  4. In�vivo G-CSF treatment activates the GR-SOCS1 axis to suppress IFN-gamma secretion by natural killer cells
    Authors: X Zhao, T Peng, X Cao, Y Hou, R Li, T Han, Z Fan, M Zhao, Y Chang, H Chen, C Li, X Huang
    Cell Reports, 2022-09-13;40(11):111342.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  5. IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence
    Authors: HY Chiang, HH Lu, JN Sudhakar, YW Chen, NS Shih, YT Weng, JW Shui
    Nature Communications, 2022-02-15;13(1):874.
    Species: Mouse
    Sample Types: Organoids
    Applications: Bioassay
  6. Interleukin-18 accelerates cardiac inflammation and dysfunction during ischemia/reperfusion injury by transcriptional activation of CXCL16
    Authors: G Zhao, H Zhang, S Zhu, S Wang, K Zhu, Y Zhao, L Xu, P Zhang, J Xie, A Sun, Y Zou, J Ge
    Cellular Signalling, 2021-09-04;0(0):110141.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  7. Chronic stress physically spares but functionally impairs innate-like invariant T�cells
    Authors: PT Rudak, J Choi, KM Parkins, KL Summers, DN Jackson, PJ Foster, AI Skaro, K Leslie, VC McAlister, VK Kuchroo, W Inoue, O Lantz, SMM Haeryfar
    Cell Reports, 2021-04-13;35(2):108979.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  8. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
    Authors: JA Moral, J Leung, LA Rojas, J Ruan, J Zhao, Z Sethna, A Ramnarain, B Gasmi, M Gururajan, D Redmond, G Askan, U Bhanot, E Elyada, Y Park, DA Tuveson, M Gönen, SD Leach, JD Wolchok, RP DeMatteo, T Merghoub, VP Balachandr
    Nature, 2020-02-19;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  9. Bystander Activation of Pulmonary Trm Cells Attenuates the Severity of Bacterial Pneumonia by Enhancing Neutrophil Recruitment
    Authors: C Ge, IR Monk, A Pizzolla, N Wang, JG Bedford, TP Stinear, GP Westall, LM Wakim
    Cell Rep, 2019-12-24;29(13):4236-4244.e3.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Cell Culture
  10. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections
    Authors: IJ Jensen, CS Winborn, MG Fosdick, P Shao, MM Tremblay, Q Shan, SK Tripathy, CM Snyder, HH Xue, TS Griffith, JC Houtman, VP Badovinac
    PLoS Pathog., 2018-10-31;14(10):e1007405.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  11. Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target.
    Authors: Jonas J Staudacher, Cemal Yazici, Timothy Carroll, Jessica Bauer, Jingbo Pang, Nancy Krett, Yinglin Xia, Annette Wilson, Georgios Papachris, Andrea Dirmeier, Claudia Kunst, David C Whitcomb, Giamila Fantuzzi, Barbara Jung
    Scientific Reports, 2017-10-06;0(0):2045-2322.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Mouse IL-18/IL-1F4 Protein

Average Rating: 5 (Based on 1 Review)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Recombinant Mouse IL-18/IL-1F4 Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Recombinant Mouse IL-18/IL-1F4 Protein
By Anonymous on 07/05/2024
Application: In vitro bioactivity in cell culture